New Zealand markets close in 2 hours 40 minutes

ILMN Jan 2025 130.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
19.00+3.25 (+20.63%)
As of 09:47AM EST. Market open.
Full screen
Previous close15.75
Open15.75
Bid17.70
Ask19.30
Strike130.00
Expiry date2025-01-17
Day's range19.00 - 19.00
Contract rangeN/A
Volume1
Open interest65
  • Zacks

    Illumina (ILMN) Rides on NGS Portfolio Expansion Amid Macro Woe

    In reproductive health, Illumina (ILMN) primarily focuses on driving noninvasive prenatal testing (NIPT) adoption globally.

  • Reuters

    Illumina, already facing pressure from Icahn, saw other activists at year end

    Gene-sequencing company Illumina, which was pushed to make changes by Carl Icahn last year, had two additional activist investors in its stock at the end of the fourth quarter, according to new regulatory filings. Keith Meister's Corvex Management disclosed buying Illumina stock during the last three months of 2023 and owning 730,084 shares on Dec. 31. The buying came after the stock price edged lower for most of the year even after investors sided with Icahn's arguments that changes were needed at the company and elected one of his director candidates to Illumina's board.

  • Insider Monkey

    Illumina, Inc. (NASDAQ:ILMN) Q4 2023 Earnings Call Transcript

    Illumina, Inc. (NASDAQ:ILMN) Q4 2023 Earnings Call Transcript February 8, 2024 Illumina, Inc. beats earnings expectations. Reported EPS is $0.14, expectations were $0.01. Illumina, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, ladies and gentlemen, and welcome […]